Bios Clinical — Full Portfolio
2 tracked investments · listed companies and verified rows first
SIRPant Immunotherapeutics, Inc.Jan 2024SEC filingmedium confidence
Hummelstown, US
Board seatJohn Fucci· per SEC Form D · $42.1M raise · filed Jan 2024
Trefoil Therapeuticstrefoiltherapeutics.cominMay 2025SEC filingmedium confidence
Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.
BiotechHealthtechMedical DevicesSan Diego, US
David Eveleth(Executive Officer, Director)Schalon Newton(Executive Officer)
BoardChristy Shaffer(Director)inRalph Bradshaw(Director)
Board seatJohn Fucci· per SEC Form D · $5M raise · filed May 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.